Quest Diagnostics Executive Catherine Doherty to Retire in July 2027
Filed with the SEC on · Summarized by InvestorsBot
Catherine T. Doherty will retire from Quest Diagnostics in July 2027 and, effective November 1, 2026, will become an executive vice president overseeing health systems, the company’s Corewell Health joint venture and Project Nova. Her annual salary will remain $650,000, with a target annual incentive of 80% of base salary, and she will receive a $1.2 million restricted-stock-unit award dated November 3, 2026.